Rivaroxaban, a novel option for patients with atrial fibrillation and a bioprosthetic mitral valve. Galiuto L, Patrono C. Eur Heart J 2021 Jan 4. pii: 6062729. doi: 10.1093/eurheartj/ehaa1075.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Galiuto L, Patrono C. Rivaroxaban, a novel option for patients with atrial fibrillation and a bioprosthetic mitral valve. Eur Heart J 2021 Jan 4. pii: 6062729. doi: 10.1093/eurheartj/ehaa1075.
PMID: 33398340